<DOC>
	<DOCNO>NCT00955669</DOCNO>
	<brief_summary>Objective : To compare effect safety autologous transplantation bone marrow mesenchymal stem cell ( MSCs ) mononuclear cell ( MNCs ) Diabetic patient Critical Limb Ischemia Foot Ulcer . Methods : patient randomize A group B group use randomization table . One low limb A group B group select randomly MSCs MNCs transplantation MSCs MNCs group , low limb patient select placebo（normal saline , NS）injection NS group . The whole procedure clinical trial blind patient investigators.Patients group receive ordinary treatment . Meanwhile , MSCs MNCs transplant impaired low limbs respectively . Follow-up index include : efficacy ( pain , ulcer heal rate , low limb amputation rate , ankle-brachial index , Transcutaneous oxygen pressure , magnetic resonance angiography ) safety ( infection injection site , immunological rejection , tumour generation ) .</brief_summary>
	<brief_title>Comparison Autologous Mesenchymal Stem Cells Mononuclear Cells Diabetic Critical Limb Ischemia Foot Ulcer</brief_title>
	<detailed_description>RESEARCH DESIGN AND METHODS Written inform consent obtain subject . Type 2 diabetic patient bilateral critical limb ischemia ( ankle-brachial index , ABI 0.30 0.60 ) least one foot ulcer , without malignant tumor gangrene ankle and/or severe coronary , cerebral renal vascular disease , eligible participation trial . Eligible patient take part study voluntary basis . They randomize A B group use randomization table . One low limb A group B group select randomly BMMSCs BMMNCs transplantation BMMSCs BMMNCs group , low limb patient select placebo（normal saline , NS）injection NS group . The whole procedure clinical trial blind patient investigator . Preparation Human Autologous Serum Preparation MSCs MNCs Flow Cytometric Analysis Examination cell Safety Administration therapy 5.0*108~5.0*109 MSCs MNCs transplant impair low limb intramuscular injection . observation index assessment guideline Statistical analysis</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>Age 40 70 year Type 2 diabetic patient bilateral critical limb ischemia ( ABI 0.30 0.60 ) least one foot ulcer dry gangrene ankle moist gangrene malignant tumor severe coronary , cerebral renal vascular disease</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>mesenchymal stem cell</keyword>
	<keyword>mononuclear cell</keyword>
</DOC>